Safety and Tolerability of GTX-104 (Nimodipine Injection for IV Infusion) Compared with Oral Nimodipine in Patients Hospitalized for Aneurysmal Subarachnoid Hemorrhage (aSAH): a Prospective, Randomized Trial
Clinical Trial Grant
Administered By
Neurosurgery
Awarded By
Acasti Pharma Inc.
Start Date
October 10, 2023
End Date
June 20, 2025
Administered By
Neurosurgery
Awarded By
Acasti Pharma Inc.
Start Date
October 10, 2023
End Date
June 20, 2025